AKOYA BIOSCIENCES INC (AKYA) Stock Price & Overview

NASDAQ:AKYA • US00974H1041

Current stock price

1.29 USD
-0.07 (-5.15%)
At close:
1.2899 USD
0 (-0.01%)
After Hours:

The current stock price of AKYA is 1.29 USD. Today AKYA is down by -5.15%. In the past month the price increased by 13.16%. In the past year, price decreased by -44.16%.

AKYA Key Statistics

52-Week Range0.931 - 3.42
Current AKYA stock price positioned within its 52-week range.
1-Month Range1.09 - 1.64
Current AKYA stock price positioned within its 1-month range.
Market Cap
64.436M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.97
Dividend Yield
N/A

AKYA Stock Performance

Today
-5.15%
1 Week
+4.03%
1 Month
+13.16%
3 Months
+4.03%
Longer-term
6 Months -57.43%
1 Year -44.16%
2 Years -81.30%
3 Years -90.84%
5 Years N/A
10 Years N/A

AKYA Stock Chart

AKOYA BIOSCIENCES INC / AKYA Daily stock chart

AKYA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to AKYA. When comparing the yearly performance of all stocks, AKYA is a bad performer in the overall market: 90.51% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AKYA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AKYA. Both the profitability and financial health of AKYA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKYA Earnings

On May 12, 2025 AKYA reported an EPS of -0.32 and a revenue of 16.64M. The company missed EPS expectations (-53.04% surprise) and missed revenue expectations (-18.23% surprise).

Next Earnings DateAug 4, 2025
Last Earnings DateMay 12, 2025
PeriodQ1 / 2025
EPS Reported-$0.32
Revenue Reported16.639M
EPS Surprise -53.04%
Revenue Surprise -18.23%

AKYA Forecast & Estimates

11 analysts have analysed AKYA and the average price target is 1.45 USD. This implies a price increase of 12.08% is expected in the next year compared to the current price of 1.29.

For the next year, analysts expect an EPS growth of 38.62% and a revenue growth 4.99% for AKYA


Analysts
Analysts50.91
Price Target1.45 (12.4%)
EPS Next Y38.62%
Revenue Next Year4.99%

AKYA Groups

Sector & Classification

Index Membership

AKYA Financial Highlights

Over the last trailing twelve months AKYA reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS increased by 31.69% compared to the year before.


Income Statements
Revenue(TTM)79.96M
Net Income(TTM)-47.53M
Industry RankSector Rank
PM (TTM) N/A
ROA -42.2%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%33.33%
Sales Q2Q%-9.32%
EPS 1Y (TTM)31.69%
Revenue 1Y (TTM)-14.55%

AKYA Ownership

Ownership
Inst Owners34.48%
Shares49.95M
Float0
Ins Owners4.15%
Short Float %N/A
Short RatioN/A

About AKYA

Company Profile

AKYA logo image Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 205 full-time employees. The company went IPO on 2021-04-16. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. The company offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays.

Company Info

IPO: 2021-04-16

AKOYA BIOSCIENCES INC

100 Campus Drive, 6th Floor

Marlborough MASSACHUSETTS US

CEO: Brian McKelligon

Employees: 330

AKYA Company Website

AKYA Investor Relations

Phone: 18558968401

AKOYA BIOSCIENCES INC / AKYA FAQ

Can you describe the business of AKOYA BIOSCIENCES INC?

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 205 full-time employees. The company went IPO on 2021-04-16. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. The company offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays.


What is the stock price of AKOYA BIOSCIENCES INC today?

The current stock price of AKYA is 1.29 USD. The price decreased by -5.15% in the last trading session.


Does AKOYA BIOSCIENCES INC pay dividends?

AKYA does not pay a dividend.


What is the ChartMill rating of AKOYA BIOSCIENCES INC stock?

AKYA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is AKYA stock listed?

AKYA stock is listed on the Nasdaq exchange.


What is the ownership structure of AKOYA BIOSCIENCES INC (AKYA)?

You can find the ownership structure of AKOYA BIOSCIENCES INC (AKYA) on the Ownership tab.